Production of Transgenic Porcine Embryos Reconstructed with Induced Pluripotent Stem-Like Cells Derived from Porcine Endogenous Factors Using piggyBac System
Restricted accessResearch articleFirst published online February, 2019
Production of Transgenic Porcine Embryos Reconstructed with Induced Pluripotent Stem-Like Cells Derived from Porcine Endogenous Factors Using piggyBac System
The potential of induced pluripotent stem (iPS) cells, which have self-renewal ability and can differentiate into three germ layers, led us to hypothesize that iPS cells in pigs can be useful and suitable source for producing transgenic pigs. In this study, we generated iPS-like cells using doxycycline-inducible piggyBac (PB) expression vectors encoding porcine 4 transcription factors. After transfection, transfected cells were cultured until the formation of outgrowing colonies taking least of 7–10 days. The iPS-like cells demonstrated pluripotent characteristics such as self-renewal, high proliferation, expression of pluripotent markers, and aggregation ability. The embryo development through somatic cell nuclear transfer (SCNT), cleavage rate, and blastocyst formation rate did not show any significant differences. However, the total cell number of blastocysts was significantly increased with the established cell line. In conclusion, the iPS-like cell line, generated from porcine transcriptional factors using the PB transposon system, demonstrated pluripotency with the capacity for unlimited self-renewal, and could be used as donor cells to produce cloned embryos by SCNT. These cells will be suitable for gene modification and would contribute to the stability or safety of pig models in biomedical research.
Get full access to this article
View all access options for this article.
References
1.
AignerB., RennerS., KesslerB., KlymiukN., KuromeM., WunschA., and WolfE. (2010). Transgenic pigs as models for translational biomedical research. J Mol Med (Berl), 88, 653–664.
2.
BaguisiA., BehboodiE., MelicanD.T., PollockJ.S., DestrempesM.M., CammusoC., WilliamsJ.L., NimsS.D., PorterC.A., MiduraP., PalaciosM.J., AyresS.L., DennistonR.S., HayesM.L., ZiomekC.A., MeadeH.M., GodkeR.A., GavinW.G., OverströmE.W., and EchelardY. (1999). Production of goats by somatic cell nuclear transfer. Nat Biotechnol, 17, 456–461.
3.
CampbellK.H., LoiP., CappaiP., and WilmutI. (1994). Improved development to blastocyst of ovine nuclear transfer embryos reconstructed during the presumptive S-phase of enucleated activated oocytes. Biol Reprod, 50, 1385–1393.
4.
CampbellK.H., LoiP., OtaeguiP.J., and WilmutI. (1996). Cell cycle co-ordination in embryo cloning by nuclear transfer. Rev Reprod, 1, 40–46.
5.
CaoH., YangP., PuY., SunX., YinH., ZhangY., ZhangY., LiY., LiuY., FangF., ZhangZ., TaoY., and ZhangX. (2012). Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins. Int J Biol Sci, 8, 498–511.
6.
CibelliJ.B., LanzaR.P., CampbellK.H., and WestM.D. (2002). Principles of Cloning. (Academic Press, San Diego).
7.
EkserB., EzzelarabM., HaraH., van der WindtD.J., WijkstromM., BottinoR., TruccoM., and CooperD.K. (2012). Clinical xenotransplantation: The next medical revolution?. Lancet, 379, 672–683.
8.
EkserB., GridelliB., VerouxM., and CooperD.K. (2011). Clinical pig liver xenotransplantation: How far do we have to go?. Xenotransplantation, 18, 158–167.
EzashiT., MatsuyamaH., TeluguB.P., and RobertsR.M. (2011). Generation of colonies of induced trophoblast cells during standard reprogramming of porcine fibroblasts to induced pluripotent stem cells. Biol Reprod, 85, 779–787.
11.
EzashiT., TeluguB.P., AlexenkoA.P., SachdevS., SinhaS., and RobertsR.M. (2009). Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A, 106, 10993–10998.
12.
FusakiN., BanH., NishiyamaA., SaekiK., and HasegawaM. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci, 85, 348–362.
13.
HanX., HanJ., DingF., CaoS., LimS.S., DaiY., ZhangR., ZhangY., LimB., and LiN. (2011). Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells. Cell Res, 21, 1509–1512.
14.
HannaJ., WernigM., MarkoulakiS., SunC.W., MeissnerA., CassadyJ.P., BeardC., BrambrinkT., WuL.C., TownesT.M., and JaenischR. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318, 1920–1923.
15.
HondaA., HiroseM., HatoriM., MatobaS., MiyoshiH., InoueK., and OguraA. (2010). Generation of induced pluripotent stem cells in rabbits: Potential experimental models for human regenerative medicine. J Biol Chem, 285, 31362–31369.
16.
ImamuraM., OkunoH., TomiokaI., KawamuraY., LinZ.Y., NakajimaR., AkamatsuW., OkanoH.J., MatsuzakiY., SasakiE., and OkanoH. (2012). Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. Methods Mol Biol, 925, 21–48.
17.
JeonH.Y., JeongY.W., KimY.W., JeongY.I., HosseinS.M., YangH., HyunS.H., JeungE.B., and HwangW.S. (2012). Senescence is accelerated through donor cell specificity in cloned pigs. Int J Mol Med, 30, 383–391.
18.
KangN.Y., YunS.W., HaH.H., ParkS.J., and ChangY.T. (2011). Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1. Nat Protoc, 6, 1044–1052.
19.
KasinathanP., KnottJ.G., WangZ., JerryD.J., and RoblJ.M. (2001). Production of calves from G1 fibroblasts. Nat Biotechnol, 19, 1176–1178.
20.
KhodadadiK., SumerH., PashaiaslM., LimS., WilliamsonM., and VermaP.J. (2012). Induction of pluripotency in adult equine fibroblasts without c-MYC. Stem Cells Int, 2012, 429160.
21.
KimE., and HyunS.H. (2014). Comparative analysis of various donor cell types for somatic cell nuclear transfer and its association with apoptosis and senescence. Mol Med Rep, 9, 63–68.
22.
KimS., SaadeldinI.M., ChoiW.J., LeeS.J., LeeW.W., KimB.H., HanH.J., Bang duH., LeeB.C., and JangG. (2011). Production of transgenic bovine cloned embryos using piggybac transposition. J Vet Med Sci, 73, 1453–1457.
23.
KimS.J., KooO.J., ParkH.J., MoonJ.H., da TorreB.R., JavaregowdaP.K., KangJ.T., ParkS.J., SaadeldinI.M., ChoiJ.Y., LeeB.C., and JangG. (2015). Oct4 overexpression facilitates proliferation of porcine fibroblasts and development of cloned embryos. Zygote, 23, 704–711.
LiJ., GaoY., PetkovS., PurupS., HyttelP., and CallesenH. (2014). Passage number of porcine embryonic germ cells affects epigenetic status and blastocyst rate following somatic cell nuclear transfer. Anim Reprod Sci, 147, 39–46.
27.
LiuJ., BalehosurD., MurrayB., KellyJ.M., SumerH., and VermaP.J. (2012). Generation and characterization of reprogrammed sheep induced pluripotent stem cells. Theriogenology, 77, 338–346.e1.
28.
LorenzoI.M., FleischerA., and BachillerD. (2013). Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells. Stem Cell Rev, 9, 435–450.
29.
MizutaniE., TorikaiK., WakayamaS., NagatomoH., OhinataY., KishigamiS., and WakayamaT. (2016). Generation of cloned mice and nuclear transfer embryonic stem cell lines from urine-derived cells. Sci Rep 6,23808.
30.
MontserratN., BahimaE.G., BatlleL., HafnerS., RodriguesA.M., GonzalezF., and Izpisua BelmonteJ.C. (2011). Generation of pig iPS cells: A model for cell therapy. J Cardiovasc Transl Res, 4, 121–130.
31.
NakagawaM., KoyanagiM., TanabeK., TakahashiK., IchisakaT., AoiT., OkitaK., MochidukiY., TakizawaN., and YamanakaS. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol, 26, 101–106.
32.
NakanoK., WatanabeM., MatsunariH., MatsudaT., HondaK., MaeharaM., KanaiT., HayashidaG., KobayashiM., KuramotoM., AraiY., UmeyamaK., FujishiroS.H., MizukamiY., NagayaM., HanazonoY., and NagashimaH. (2013). Generating porcine chimeras using inner cell mass cells and parthenogenetic preimplantation embryos. PLoS One 8,e61900.
33.
NicholsJ., and SmithA. (2009). Naive and primed pluripotent states. Cell Stem Cell, 4, 487–492.
34.
ObackB., and WellsD. (2002). Donor cells for nuclear cloning: Many are called, but few are chosen. Cloning Stem Cells, 4, 147–168.
35.
ParkI.H., ZhaoR., WestJ.A., YabuuchiA., HuoH., InceT.A., LerouP.H., LenschM.W., and DaleyG.Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141–146.
36.
ParkS.J., ChoB., KooO.J., KimH., KangJ.T., HurhS., KimS.J., YeomH.J., MoonJ., LeeE.M., ChoiJ.Y., HongJ.H., JangG., HwangJ.I., YangJ., LeeB.C., AhnC. (2014). Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide. Transgenic Res, 23, 407–419.
37.
PolejaevaI.A., ChenS.H., VaughtT.D., PageR.L., MullinsJ., BallS., DaiY., BooneJ., WalkerS., AyaresD.L., ColmanA., and CampbellK.H. (2000). Cloned pigs produced by nuclear transfer from adult somatic cells. Nature, 407, 86–90.
38.
RichterA., KuromeM., KesslerB., ZakhartchenkoV., KlymiukN., NagashimaH., WolfE., and WuenschA. (2012). Potential of primary kidney cells for somatic cell nuclear transfer mediated transgenesis in pig. BMC Biotechnol, 12, 84.
39.
RideoutW.M.3rd, WakayamaT., WutzA., EgganK., Jackson-GrusbyL., DausmanJ., YanagimachiR., and JaenischR. (2000). Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nat Genet, 24, 109–110.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
42.
TakahashiK., and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
43.
TalluriT.R., KumarD., GlageS., GarrelsW., IvicsZ., DebowskiK., BehrR., NiemannH., and KuesW.A. (2015). Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming. Cell Reprogram, 17, 131–140.
44.
TianX.C., KubotaC., EnrightB., and YangX. (2003). Cloning animals by somatic cell nuclear transfer—Biological factors. Reprod Biol Endocrinol 1,98.
45.
WakayamaT., PerryA.C., ZuccottiM., JohnsonK.R., and YanagimachiR. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature, 394, 369–374.
46.
WakayamaT., RodriguezI., PerryA.C., YanagimachiR., and MombaertsP. (1999). Mice cloned from embryonic stem cells. Proc Natl Acad Sci U S A, 96, 14984–14989.
47.
WangQ.H., PengY., CaiX.Y., WanM., LiuY., and WeiH. (2015). Nucleus transfer efficiency of ear fibroblast cells isolated from Bama miniature pigs at various ages. J Huazhong Univ Sci Technolog Med Sci, 35, 585–590.
48.
WellsD.N., LaibleG., TuckerF.C., MillerA.L., OliverJ.E., XiangT., ForsythJ.T., BergM.C., CockremK., L'HuillierP.J., TervitH.R., and ObackB. (2003). Coordination between donor cell type and cell cycle stage improves nuclear cloning efficiency in cattle. Theriogenology, 59, 45–59.
49.
WestF.D., UhlE.W., LiuY., StoweH., LuY., YuP., Gallegos-CardenasA., PrattS.L., and SticeS.L. (2011). Brief report: Chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs. Stem Cells, 29, 1640–1643.
50.
WhitworthD.J., OvchinnikovD.A., SunJ., FortunaP.R., and WolvetangE.J. (2014). Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev, 23, 1515–1523.
51.
WilmutI., SchniekeA.E., McWhirJ., KindA.J., and CampbellK.H. (2007). Viable offspring derived from fetal and adult mammalian cells. Cloning Stem Cells, 9, 3–7.
WuS.C., MeirY.J., CoatesC.J., HandlerA.M., PelczarP., MoisyadiS., and KaminskiJ.M. (2006). piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci U S A, 103, 15008–15013.
54.
WuZ., ChenJ., RenJ., BaoL., LiaoJ., CuiC., RaoL., LiH., GuY., DaiH., ZhuH., TengX., ChengL., and XiaoL. (2009). Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol, 1, 46–54.
55.
YangX., SmithS.L., TianX.C., LewinH.A., RenardJ.P., and WakayamaT. (2007). Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet, 39, 295–302.
56.
YoshiokaK., SuzukiC., TanakaA., AnasI.M., and IwamuraS. (2002). Birth of piglets derived from porcine zygotes cultured in a chemically defined medium. Biol Reprod, 66, 112–119.
57.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinI.I., and ThomsonJ.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
58.
ZhengY.M., ZhaoH.Y., ZhaoX.E., QuanF.S., HuaS., HeX.Y., LiuJ., HeX.N., and LinH. (2009). Development of cloned embryos from porcine neural stem cells and amniotic fluid-derived stem cells transfected with enhanced green fluorescence protein gene. Reproduction, 137, 793–801.
59.
ZhouW., and FreedC.R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27, 2667–2674.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
